These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 35099759)
1. Nanozyme-Based Enhanced Cancer Immunotherapy. Phan NM; Nguyen TL; Kim J Tissue Eng Regen Med; 2022 Apr; 19(2):237-252. PubMed ID: 35099759 [TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia. Lv W; Cao M; Liu J; Hei Y; Bai J Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474 [TBL] [Abstract][Full Text] [Related]
3. "Spark" PtMnIr Nanozymes for Electrodynamic-Boosted Multienzymatic Tumor Immunotherapy. Li D; Ha E; Zhou Z; Zhang J; Zhu Y; Ai F; Yan L; He S; Li L; Hu J Adv Mater; 2024 Mar; 36(13):e2308747. PubMed ID: 38108600 [TBL] [Abstract][Full Text] [Related]
4. ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy. Mo W; Liu S; Zhao X; Wei F; Li Y; Sheng X; Cao W; Ding M; Zhang W; Chen X; Meng L; Yao S; Diao W; Wei H; Guo H Adv Healthc Mater; 2023 Aug; 12(21):e2300191. PubMed ID: 37031357 [TBL] [Abstract][Full Text] [Related]
5. Nanozymes: From New Concepts, Mechanisms, and Standards to Applications. Liang M; Yan X Acc Chem Res; 2019 Aug; 52(8):2190-2200. PubMed ID: 31276379 [TBL] [Abstract][Full Text] [Related]
6. Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation/Chemodynamic /Immunotherapy. Wang M; Chang M; Li C; Chen Q; Hou Z; Xing B; Lin J Adv Mater; 2022 Jan; 34(4):e2106010. PubMed ID: 34699627 [TBL] [Abstract][Full Text] [Related]
7. Confining Prepared Ultrasmall Nanozymes Loading ATO for Lung Cancer Catalytic Therapy/Immunotherapy. Zhang A; Gao A; Zhou C; Xue C; Zhang Q; Fuente JM; Cui D Adv Mater; 2023 Nov; 35(45):e2303722. PubMed ID: 37748441 [TBL] [Abstract][Full Text] [Related]
8. Sm/Co-Doped Silica-Based Nanozymes Reprogram Tumor Microenvironment for ATP-Inhibited Tumor Therapy. Li S; Ding H; Chang J; Liu S; Dong S; Zyuzin MV; Timin AS; Feng L; He F; Gai S; Yang P Adv Healthc Mater; 2023 Sep; 12(24):e2300652. PubMed ID: 37306377 [TBL] [Abstract][Full Text] [Related]
9. A Cascade Nanozyme with Amplified Sonodynamic Therapeutic Effects through Comodulation of Hypoxia and Immunosuppression against Cancer. Tao N; Li H; Deng L; Zhao S; Ouyang J; Wen M; Chen W; Zeng K; Wei C; Liu YN ACS Nano; 2022 Jan; 16(1):485-501. PubMed ID: 34962762 [TBL] [Abstract][Full Text] [Related]
10. Combining Cobalt Ferrite Nanozymes with a Natural Enzyme to Reshape the Tumor Microenvironment for Boosted Cascade Enzyme-Like Activities. Chang J; Qin X; Li S; He F; Gai S; Ding H; Yang P ACS Appl Mater Interfaces; 2022 Oct; 14(40):45217-45228. PubMed ID: 36190449 [TBL] [Abstract][Full Text] [Related]
11. Nanozyme-based medicine for enzymatic therapy: progress and challenges. Wang Q; Jiang J; Gao L Biomed Mater; 2021 Mar; 16(4):. PubMed ID: 33601365 [TBL] [Abstract][Full Text] [Related]
12. Programmed Targeting Pyruvate Metabolism Therapy Amplified Single-Atom Nanozyme-Activated Pyroptosis for Immunotherapy. Niu R; Liu Y; Xu B; Deng R; Zhou S; Cao Y; Li W; Zhang H; Zheng H; Song S; Wang Y; Zhang H Adv Mater; 2024 Jun; 36(24):e2312124. PubMed ID: 38314930 [TBL] [Abstract][Full Text] [Related]
13. ROS scavenging Mn Yao J; Cheng Y; Zhou M; Zhao S; Lin S; Wang X; Wu J; Li S; Wei H Chem Sci; 2018 Mar; 9(11):2927-2933. PubMed ID: 29732076 [TBL] [Abstract][Full Text] [Related]
14. Novel PdPtCu Nanozymes for Reprogramming Tumor Microenvironment to Boost Immunotherapy Through Endoplasmic Reticulum Stress and Blocking IDO-Mediated Immune Escape. Xie Y; Wang M; Qian Y; Li L; Sun Q; Gao M; Li C Small; 2023 Nov; 19(44):e2303596. PubMed ID: 37394715 [TBL] [Abstract][Full Text] [Related]
15. Remodeling of Tumor Microenvironment by Nanozyme Combined cGAS-STING Signaling Pathway Agonist for Enhancing Cancer Immunotherapy. Dong W; Chen M; Chang C; Jiang T; Su L; Chen C; Zhang G Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762239 [TBL] [Abstract][Full Text] [Related]
16. Chirality-Dependent Reprogramming of Macrophages by Chiral Nanozymes. Zhang Y; Cui T; Yang J; Huang Y; Ren J; Qu X Angew Chem Int Ed Engl; 2023 Aug; 62(34):e202307076. PubMed ID: 37309708 [TBL] [Abstract][Full Text] [Related]
17. Iron phthalocyanine-derived nanozyme as dual reactive oxygen species generation accelerator for photothermally enhanced tumor catalytic therapy. Nan F; Jia Q; Xue X; Wang S; Liu W; Wang J; Ge J; Wang P Biomaterials; 2022 May; 284():121495. PubMed ID: 35429814 [TBL] [Abstract][Full Text] [Related]
18. Au@Pd nanozyme-mediated catalytic therapy: a novel strategy for targeting tumor microenvironment in cancer treatment. Luo M; Zhao FK; Wang YM; Bian J J Transl Med; 2024 Sep; 22(1):814. PubMed ID: 39223625 [TBL] [Abstract][Full Text] [Related]
19. Advances in metal-organic framework-based nanozymes in ROS scavenging medicine. Xu Z; Chen L; Luo Y; Wei YM; Wu NY; Luo LF; Wei YB; Huang J Nanotechnology; 2024 Jun; 35(36):. PubMed ID: 38865988 [TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis. Zhu L; Dai Y; Gao L; Zhao Q Int J Nanomedicine; 2021; 16():4559-4577. PubMed ID: 34267513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]